{"id":15596,"date":"2020-10-23T16:28:24","date_gmt":"2020-10-23T10:58:24","guid":{"rendered":"http:\/\/udaen.info\/?p=15596"},"modified":"2020-10-23T16:28:24","modified_gmt":"2020-10-23T10:58:24","slug":"big-boost-to-indias-indigenous-vaccine-plan-as-bharat-biotech-gets-clearance-for-phase-iii-trials","status":"publish","type":"post","link":"https:\/\/udaen.info\/?p=15596","title":{"rendered":"Big boost to India&#8217;s indigenous vaccine plan as Bharat Biotech gets clearance for phase III trials"},"content":{"rendered":"<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-xs-12\">\n<h1 class=\"news_heading detail_title\">Big boost to India&#8217;s indigenous vaccine plan as Bharat Biotech gets clearance for phase III trials<\/h1>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"panel-display panel-1col clearfix\">\n<div class=\"panel-panel panel-col\">\n<div>\n<div class=\"panel-pane pane-panels-mini pane-news-details\">\n<div id=\"mini-panel-news_details\" class=\"panel-display panel-2col clearfix\">\n<div class=\"panel-panel panel-col-first\">\n<div class=\"inside\">\n<div class=\"panel-pane pane-views pane-news\">\n<div class=\"view view-news view-id-news view-display-id-block view-dom-id-6270eb5c709f74472e376a38c215b789\">\n<div class=\"view-content\">\n<div class=\"item-list\">\n<ul>\n<li class=\"views-row views-row-1 views-row-odd views-row-first views-row-last\">\n<div>\n<div class=\"social_share detail_share\">\n<p class=\"date\">23-10-2020 | 11:20 am<\/p>\n<div class=\"social_share_box\"><span class=\"share\">Share Now<img decoding=\"async\" class=\"contrast_light\" src=\"http:\/\/ddnews.gov.in\/sites\/all\/themes\/cmf\/theme\/images\/share.png\" alt=\"\" \/><\/span><\/p>\n<ul class=\"sharebtns\">\n<li class=\"s_icons\"><a class=\"facebook\" title=\"The in%2Fhealth%2Fbig-boost-indias-indigenous-vaccine-plan-bharat-biotech-gets-clearance-phase-iii-trials file Open in new window\" role=\"link\" href=\"https:\/\/www.facebook.com\/sharer.php?u=http%3A%2F%2Fddnews.gov.in%2Fhealth%2Fbig-boost-indias-indigenous-vaccine-plan-bharat-biotech-gets-clearance-phase-iii-trials\" target=\"_BLANK\">Share on Facebook<\/a><\/li>\n<li class=\"s_icons\"><a class=\"twitter\" title=\"The in%2Fhealth%2Fbig-boost-indias-indigenous-vaccine-plan-bharat-biotech-gets-clearance-phase-iii-trials file Open in new window\" role=\"link\" href=\"http:\/\/twitter.com\/share?url=http%3A%2F%2Fddnews.gov.in%2Fhealth%2Fbig-boost-indias-indigenous-vaccine-plan-bharat-biotech-gets-clearance-phase-iii-trials\" target=\"_BLANK\">Share on Twitter<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"views-field views-field-php-1\"><span class=\"field-content\"><img decoding=\"async\" title=\"Big boost to India's indigenous vaccine plan as Bharat Biotech gets clearance for phase III trials\" src=\"http:\/\/ddnews.gov.in\/sites\/default\/files\/covaxin_2.jpg\" alt=\"Big boost to India's indigenous vaccine plan as Bharat Biotech gets clearance for phase III trials\" \/><\/span><\/div>\n<div>\n<div class=\"news_content\">\n<p class=\"heading_small\">In a huge boost to India&#8217;s indigenous vaccine plan, Bharat Biotech has been given clearance for phase three trials in India.<\/p>\n<p>Covaxin&#8217;s third phase trials will start in the first week of November.<\/p>\n<p>Under the Phase 3 trial, vaccine will be administered to 22 thousand people across 19 places.<\/p>\n<p>The government aims to vaccinate 20 to 25 crore people between January and July next year.<\/p>\n<p>The government has also sought a list of all those who will be given the vaccine. Initially vaccine will be given on priority basis.<\/p>\n<p>It is to be noted that India manufacturers around 60% of vaccine supplies worldwide.<\/p>\n<\/div>\n<\/div>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"panel-panel panel-col-last\">\n<div class=\"inside\">\n<div class=\"panel-pane pane-custom pane-1\">\n<div class=\"row pre_next s-pre\">\n<div class=\"col-md-2 col-sm-6 col-xs-6\">\n<div class=\"previous\"><a href=\"http:\/\/ddnews.gov.in\/health\/india%E2%80%99s-active-cases-below-10-total-cases-last-three-days\"><img decoding=\"async\" src=\"http:\/\/ddnews.gov.in\/sites\/default\/files\/Covid_24.jpg\" alt=\"India\u2019s active cases below 10% of total cases since the last three days\" \/><\/a><\/p>\n<p class=\"previous_title\">India\u2019s active cases below 10% of total cases since the last three days<\/p>\n<p class=\"previous_link\"><strong>Previous<\/strong><br \/>\nStory<\/p>\n<\/div>\n<\/div>\n<div class=\"col-sm-8 mob_hide\"><\/div>\n<\/div>\n<div class=\"row pre_next s-next\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"panel-pane pane-views pane-related-articles\">\n<h2 class=\"pane-title pane__title\">RELATED STORY<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Big boost to India&#8217;s indigenous vaccine plan as Bharat Biotech gets clearance for phase III trials 23-10-2020 | 11:20 am Share Now Share on Facebook Share on Twitter In a huge boost to India&#8217;s indigenous vaccine plan, Bharat Biotech has been given clearance for phase three trials in India. Covaxin&#8217;s third phase trials will start [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_monsterinsights_skip_tracking":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts\/15596"}],"collection":[{"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15596"}],"version-history":[{"count":1,"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts\/15596\/revisions"}],"predecessor-version":[{"id":15597,"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts\/15596\/revisions\/15597"}],"wp:attachment":[{"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}